Lie Hai
liked
if u buy→ $ProShares UltraPro Short QQQ ETF (SQQQ.US)$,
its simply not against all odds
you r simply against all Gods
imho only madmen buy SQQQ tbh
last friday directly -8% lols. WTH is my fate...
its simply not against all odds
you r simply against all Gods
imho only madmen buy SQQQ tbh
last friday directly -8% lols. WTH is my fate...

Unsupported feature.
Please use the mobile app.
4
6
Lie Hai
liked
$Super Micro Computer (SMCI.US)$ Crap, it’s going to rain again.
Translated
1
3
$Tempus AI (TEM.US)$ It's interesting, I thought it had dropped a lot and added some again, only to find out that it's still halfway up the mountain, stuck inside.
Translated
1
Lie Hai
liked
Recently, the AI Medical Technology company $Tempus AI (TEM.US)$ (NASDAQ: TEMS) announced its latest Earnings Reports, and the stock price fell sharply at one point 17%, raising widespread concern in the market. Investors can't help but ask, is this an opportunity of market mispricing, or are there fundamental issues with the company? This article will analyze from the revenue data, cost structure, and financial health. and Market trends From various angles, a comprehensive analysis of the investment value of Tempus AI is conducted, and whether it is worth paying attention to future stock price rebound opportunities is explored.
Revenue is growing steadily, but the net loss is still expanding.
According to the latest Earnings Reports,Tempus AI's Q4 2024 revenue reached 0.2007 billion USD, a year-on-year increase of 35.8%.This shows that the company's Business expansion momentum remains strong. Among them,the Genomics department generated revenue of 0.1204 billion dollars, growing by 30.6%.WhileMeanwhile, the Data & Services department increased by 44.6%, reaching 80.2 million dollars.。
However, the company's ongoing expansion has led to rising costs, affecting its ultimate profitability in Q4 2024. The net loss reached 13 million dollars., the annual net loss reached 0.7058 billion USDwhich includes 0.324 billion USD in Stocks compensation costs. Despite continuous revenue growth, the market is concerned...
Revenue is growing steadily, but the net loss is still expanding.
According to the latest Earnings Reports,Tempus AI's Q4 2024 revenue reached 0.2007 billion USD, a year-on-year increase of 35.8%.This shows that the company's Business expansion momentum remains strong. Among them,the Genomics department generated revenue of 0.1204 billion dollars, growing by 30.6%.WhileMeanwhile, the Data & Services department increased by 44.6%, reaching 80.2 million dollars.。
However, the company's ongoing expansion has led to rising costs, affecting its ultimate profitability in Q4 2024. The net loss reached 13 million dollars., the annual net loss reached 0.7058 billion USDwhich includes 0.324 billion USD in Stocks compensation costs. Despite continuous revenue growth, the market is concerned...
Translated

3
$Maybank Retail Money Market-I Fund (MYU0100A2266.MF)$ Is this worth investing in?
Translated
1
1
Lie Hai
commented on
$KOPI (0338.MY)$ What do you think the highest can reach today?
Translated
2
Lie Hai
liked
I don't know if everyone has bought it.COFFEE I have already bought it anyway, the price is 0.8, so it shouldn't be too high. I hope it can slowly and steadily rise so I can have a free cup of coffee every day. Thank you, everyone.![]()
$KOPI (0338.MY)$
$KOPI (0338.MY)$
Translated
4
2